Literature DB >> 25905813

Circulating mortalin autoantibody--a new serological marker of liver cirrhosis.

Wen-Jing Lu1, Nishant Saxena, John M Luk, Sunil C Kaul, Renu Wadhwa.   

Abstract

Mortalin is a stress chaperone belonging to the Hsp70 family of proteins. Frequently enriched in cancers, it is a multifunctional protein and regulates cell proliferation, apoptosis, mitochondrial functions, and the activity of tumor suppressor protein p53. In the present study, we investigated circulating mortalin and its autoantibody in normal, cirrhosis, and cancerous liver. We found that although mortalin is enriched in liver cancer cells and tumors, it is not detected in the serum of either the liver cirrhosis or cancer patients. In contrast, mortalin autoantibody was detected in patients' sera and showed significant correlation with the occurrence of cirrhosis. It is suggested as a potential noninvasive marker for liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25905813      PMCID: PMC4463917          DOI: 10.1007/s12192-015-0592-1

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  25 in total

1.  Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.

Authors:  Renu Wadhwa; Syuichi Takano; Kamaljit Kaur; Custer C Deocaris; Olivia M Pereira-Smith; Roger R Reddel; Sunil C Kaul
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

2.  Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.

Authors:  Yukiko Saitou; Katsuya Shiraki; Yutaka Yamanaka; Yumi Yamaguchi; Tomoyuki Kawakita; Norihiko Yamamoto; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

3.  TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.

Authors:  Christina Klaus; Elke Kaemmerer; Andrea Reinartz; Ursula Schneider; Patrick Plum; Min Kyung Jeon; Josephine Hose; Franziska Hartmann; Martina Schnölzer; Norbert Wagner; Jürgen Kopitz; Nikolaus Gassler
Journal:  Cell Tissue Res       Date:  2014-04-29       Impact factor: 5.249

4.  Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer.

Authors:  Perri Rozenberg; Judit Kocsis; Moran Saar; Zoltán Prohászka; George Füst; Zvi Fishelson
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

5.  Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Authors:  Scott D Holmberg; Mei Lu; Loralee B Rupp; Lois E Lamerato; Anne C Moorman; Vinutha Vijayadeva; Joseph A Boscarino; Emily M Henkle; Stuart C Gordon
Journal:  Clin Infect Dis       Date:  2013-04-16       Impact factor: 9.079

Review 6.  Diagnosis and epidemiology of cirrhosis.

Authors:  Harvey B Lefton; Anthony Rosa; Matthew Cohen
Journal:  Med Clin North Am       Date:  2009-07       Impact factor: 5.456

7.  Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.

Authors:  Tamara N Pereira; Peter J Lewindon; Jeffery L Smith; Therese L Murphy; Douglas J Lincoln; Ross W Shepherd; Grant A Ramm
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

8.  Identification and functional characterization of nuclear mortalin in human carcinogenesis.

Authors:  Jihoon Ryu; Zeenia Kaul; A-Rum Yoon; Ye Liu; Tomoko Yaguchi; Youjin Na; Hyo Min Ahn; Ran Gao; Il-Kyu Choi; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

9.  Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Authors:  Xin Yi; John M Luk; Nikki P Lee; Jirun Peng; Xisheng Leng; Xin-Yuan Guan; George K Lau; Laura Beretta; Sheung-Tat Fan
Journal:  Mol Cell Proteomics       Date:  2007-10-14       Impact factor: 5.911

10.  Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

Authors:  Thierry Poynard; Françoise Imbert-Bismut; Mona Munteanu; Djamila Messous; Robert P Myers; Dominique Thabut; Vlad Ratziu; Anne Mercadier; Yves Benhamou; Bernard Hainque
Journal:  Comp Hepatol       Date:  2004-09-23
View more
  3 in total

1.  Mitochondrial Hsp70 and the troubles of nomenclature: leaving behind tradition to gain intuitiveness and clarity.

Authors:  Peter Bross; Robert M Tanguay
Journal:  Cell Stress Chaperones       Date:  2016-05-22       Impact factor: 3.667

2.  Involvement and Targeted Intervention of Mortalin-Regulated Proteome Phosphorylated-Modification in Hepatocellular Carcinoma.

Authors:  Ye Yang; Ming Jin; Yi Dai; Wenqi Shan; Shuai Chen; Rong Cai; Haojun Yang; Liming Tang; Lei Li
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

Review 3.  Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's disease.

Authors:  Baptiste Texier; Morgane Prime; Djamaa Atamena; Pascale Belenguer; Marion Szelechowski
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.